- Home
- CVLT vs RVMD Comparison
CVLT vs RVMD Comparison
Compare CVLT & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVLT
- RVMD
- Stock Information
- Founded
- CVLT 1996
- RVMD 2014
- Country
- CVLT United States
- RVMD United States
- Employees
- CVLT N/A
- RVMD N/A
- Industry
- CVLT Computer Software: Prepackaged Software
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CVLT Technology
- RVMD Health Care
- Exchange
- CVLT Nasdaq
- RVMD Nasdaq
- Market Cap
- CVLT 6.8B
- RVMD 7.4B
- IPO Year
- CVLT 2006
- RVMD 2020
- Fundamental
- Price
- CVLT $183.15
- RVMD $39.40
- Analyst Decision
- CVLT Buy
- RVMD Strong Buy
- Analyst Count
- CVLT 10
- RVMD 12
- Target Price
- CVLT $182.75
- RVMD $68.67
- AVG Volume (30 Days)
- CVLT 432.0K
- RVMD 2.0M
- Earning Date
- CVLT 04-29-2025
- RVMD 05-07-2025
- Dividend Yield
- CVLT N/A
- RVMD N/A
- EPS Growth
- CVLT N/A
- RVMD N/A
- EPS
- CVLT 1.68
- RVMD N/A
- Revenue
- CVLT $995,619,000.00
- RVMD N/A
- Revenue This Year
- CVLT $15.91
- RVMD N/A
- Revenue Next Year
- CVLT $11.79
- RVMD $241.39
- P/E Ratio
- CVLT $109.02
- RVMD N/A
- Revenue Growth
- CVLT 18.63
- RVMD N/A
- 52 Week Low
- CVLT $105.76
- RVMD $29.17
- 52 Week High
- CVLT $190.11
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- CVLT 62.67
- RVMD 51.81
- Support Level
- CVLT $170.00
- RVMD $36.53
- Resistance Level
- CVLT $178.76
- RVMD $40.00
- Average True Range (ATR)
- CVLT 5.12
- RVMD 1.80
- MACD
- CVLT -0.29
- RVMD -0.21
- Stochastic Oscillator
- CVLT 91.45
- RVMD 47.28
About CVLT Commvault Systems Inc.
CommVault Systems Inc provides data and information management software applications and services. The firm sells software licenses and services to large global enterprises, small- and midsize businesses, and government agencies through both its salesforce and its network of reseller partners. Its software solutions include Commvault Complete Backup and Recovery, HyperScale, Hedvig, and Metallic. The company operates in the United States and exports to many other countries.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.